Contact Us | Home
Toll Free No. for USA/Canada:   1-866-279-8368
| Advance Search
 
Currency:  $ £
Discounted Reports
MARKET RESEARCH SECTOR IN FOCUS
Energy & Resources
FMCG & Retailing
Pharmaceuticals and Healthcare
Textiles
MARKET REPORT DETAIL

Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on North America

Enquire | Email | Print

Single User - $5,370       2 to 5 Users - $6,850       6 to 10 Users - $8,460       11to 20 Users - $10,050       21+ Users - $12,450
Published Date: Sep, 2011
Format: PDF
No of Pages: 189
 
 
Select pricing :
Change Currency: EURO | $ USD | £ GBP
Buy through us and save. We do not add any Tax / Duty including VAT,GST
  • Abstract
  • Table of Contents

REPORT HIGHLIGHTS

  • The global pharmaceutical contract manufacturing and contract research organizations revenue reached at $196.5 billion in 2010, it will further grow to $217.9 billion in 2011 and is projected to reach at $360.6 billion by 2016, increasing at a compound annual growth rate (CAGR) of 10.6%.
  • North American markets’ revenue for bulk drugs in contract manufacturing in 2009 was about $8.8 billion and increased to about $9.7 billion in 2010. It is projected to reach $16.6 billion by 2016, for a 5-year CAGR of 9.4%.
  • The total market for solid dosage form contract manufacturing in 2010 was valued at about $9.1 billion. This is expected to reach $10 billion by 2011 and forecasted to cross $16.1 billion by the end of 2016 at a CAGR of 10% for the five year period.

INTRODUCTION

STUDY OBJECTIVE

The objective of BCC Research in conducting this study is to provide an overview of the current situation and future capabilities of the global pharmaceutical contract manufacturing, research, and packaging markets.  The study provides a global as well as a regionally specific market overview.  The report emphasizes the current and future outlook of the pharmaceutical contract manufacturing market, with a comprehensive analysis of the overall pharmaceutical and biotechnology outsourcing industry. 

The current report discusses and outlines the current capabilities as well as the needs of the pharmaceutical contract manufacturing, research, and packaging markets.  In addition, it discusses company and market strategies to further enhance the market.  The report includes the different types of contract manufacturing and, more specifically, the services offered by global contract manufacturers, researchers, and packagers.  The report also discusses the methods best used to identify an effective contract manufacturer as well as the advantages of contract manufacturing and outsourcing.  The report highlights the need for project management, provides market forecasts for different aspects of contract manufacturing specific to each region, and examines the role of market leaders in the industry.  Regulatory requirements and new developments in the market are also discussed in the report.

The report encompasses the revenues gained from contract manufacturing in each specific market and in each specific region.  Sales analysis was performed on specific categories of drugs and dosage forms including API/bulk drugs and solid, liquid, and semisolid dosage forms.  Sales analyses were also performed on revenues gained from contract packaging and contract research.  The sales figures discussed are for the examined period of 2009 to 2011.  Sales figures were also forecast for the following 5-year period from 2011 through 2016.
Over-the-counter (OTC) drugs, nutritional drugs, and drug delivery products are discussed in a separate section of this report.

REASONS FOR DOING THIS STUDY
The majority of pharmaceutical companies are now using contract manufacturing, research, and packaging services.  To save costs and product development time while simultaneously being effective, efficient, and productive, pharmaceutical companies are relying on contract manufacturers to fulfill many basic as well as specialized competencies.  This study discusses the different types of contracting companies, their roles, and the share of the market they claim.  New developments and new technologies warrant the issuing of this report, which is an important resource for anyone analyzing the discussed markets.

Trends in outsourcing and new emerging markets for outsourcing are providing a new look to the market and greater options to pharmaceutical companies.  The industry is seeing an increase in outsourcing as contract manufacturers, researchers, and packagers provide cheaper options as well as region-specific suppliers.  The new state-of-the-art packaging facilities as well as expensive research facilities and capabilities of research organizations are enhancing the overall growth of the contract manufacturing industry.  Contract manufacturers are providing pharmaceutical companies with expertise in all forms that the companies do not have available in-house.

INTENDED AUDIENCE
This study examines the areas of market growth in pharmaceuticals contract manufacturing, research, and packaging from the point of view of manufacturers and users.  Strategic decision makers at biochemical and biotechnology companies, physicians, pharmaceuticals and biopharmaceuticals companies, and related research companies will find value in this study.  

SCOPE OF THE STUDY
The scope of this study encompasses the contract manufacturing, research, and packaging markets.  BCC analyzes each market and its applications for contract manufacturing by its need for outsourcing, regulatory environment, technology involved, market projections, and market share.  Technological issues include the latest trends and developments. 

METHODOLOGY
Both primary and secondary research methodologies were used in preparing this study.  BCC conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources.  Data were collected through interviews and correspondence with various analytical, chemical, pharmaceutical, and contracting experts.  Market sizing estimates and projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.

INFORMATION SOURCES
Many companies within the industry were surveyed to obtain data for this study.  Included were manufacturers and end users of pharmaceuticals through contract manufacturing and research.  Data were gathered from various industry sources.  BCC spoke with officials and physicians within the industry, and consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes, and abstracts.  Exhaustive investigations of databases by key terminology were completed.  In addition, data were compiled from current financial, trade, and government sources.


Table of Contents :

Chapter- 1: INTRODUCTION - Complimentary 4 $0
STUDY OBJECTIVE
REASONS FOR DOING THIS STUDY
INTENDED AUDIENCE
SCOPE OF THE STUDY
METHODOLOGY
INFORMATION SOURCES

Chapter- 2: SUMMARY 3 $150
Table 0 : GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE, THROUGH 2016
Figure 0 : GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE, 2009-2016

Chapter- 3: OVERVIEW 4 $124
DEFINITIONS
HISTORY OF OUTSOURCING
Table 1 : KEY DEVELOPMENTS IN THE HISTORY OF OUTSOURCING

Chapter- 4: OVERVIEW OF CONTRACT MANUFACTURING 5 $155
TYPES OF CONTRACT MANUFACTURERS
CONTRACT MANUFACTURING TRAITS
ADVANTAGES AND DISADVANTAGES OF CONTRACT MANUFACTURING
SELECTING A CONTRACT MANUFACTURER
ADDITIONAL FACTS ABOUT CONTRACT MANUFACTURING

Chapter- 5: OVERVIEW OF CONTRACT RESEARCH 5 $155
SERVICES OFFERED BY CONTRACT RESEARCH ORGANIZATIONS
SELECTING A CONTRACT RESEARCH ORGANIZATION
RESEARCH PROVIDED BY CONTRACT RESEARCH ORGNIZATIONS
Table 7 : TYPES OF RESEARCH PROVIDED BY CONTRACT RESEARCH ORGANIZATIONS

Chapter- 6: OVERVIEW OF CONTRACT PACKAGING 5 $155
NEEDING A CONTRACT PACKAGER
SELECTING A CONTRACT PACKAGER
HIRING A CONTRACT PACKAGER
TYPES OF PACKAGING

Chapter- 7: PROJECT MANAGEMENT 5 $155
SPECIFICATIONS OF PROJECT MANAGEMENT
PROCESSES OF PROJECT MANAGEMENT
FACTORS INVOLVED
ROLE OF THE PROJECT MANAGER
TECHNOLOGY TRANSFER
Table 14 : TECHNOLOGY TRANSFER STEPS

Chapter- 8: REGULATORY ASPECTS 9 $279
WARNING LETTERS
REGULATORY APPROVALS
Table 19 : REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND FACILITIES, JANUARY THROUGH MARCH, 2011
Table 20 : REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND FACILITIES, 2010
Table 21 : REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND FACILITIES, 2009

Chapter- 9: INDUSTRY STRUCTURE FOR NORTH AMERICA 10 $310
MARKET SHARE OF INDUSTRY LEADERS
CONTRACT MANUFACTURERS OF BULK DRUGS AND API’S
CONTRACT MANUFACTURERS OF SOLID-DOSAGE FORMS
CONTRACT MANUFACTURERS OF LIQUID DOSAGE FORMS
CONTRACT MANUFACTURERS OF SEMISOLID DOSAGE FORMS
CONTRACT RESEARCH COMPANIES
CONTRACT PACKAGING COMPANIES
Table 28 : MARKET SHARE OF CONTRACT PACKAGING COMPANIES, IN NORTH AMERICA 2010
Figure 7 : MARKET SHARE OF CONTRACT PACKAGING COMPANIES, IN NORTH AMERICA, 2010

Chapter- 10: TECHNOLOGY TRANSFER 7 $217
REASONS FOR TECHNOLOGY TRANSFER
CHALLENGING PROBLEMS DURING TECHNOLOGY TRANSFER
TECHNOLOGY TRANSFER
TYPES OF CONTRACTUAL AGREEMENTS USED IN TECHNOLOGY TRANSFER
CHARACTERISTICS OF A SUCCESSFUL PROJECT

Chapter- 11: NEW DEVELOPMENTS 5 $155
LONZA
ABBOTT
HOSPIRA
COVIDIEN
OTHER

Chapter- 12: MARKET ANALYSIS FOR NORTH AMERICA 42 $1300
CONTRACT MANUFACTURING
CONTRACT RESEARCH
CONTRACT PACKAGING

Chapter- 13: MARKET SHARE BY REGION 10 $310
MARKET SHARE OF CONTRACT MANUFACTURED API’S
MARKET SHARE OF CONTRACT MANUFACTURED SOLID DOSAGE FORMS
MARKET SHARE OF CONTRACT MANUFACTURED LIQUID DOSAGE FORMULATIONS
MARKET SHARE OF CONTRACT MANUFACTURED SEMISOLID DOSAGE FORMULATIONS
MARKET SHARE OF CONTRACT MANUFACTURED ADVANCED DRUG DELIVERY PRODUCTS
MARKET SHARE OF CONTRACT MANUFACTURED OTC AND NUTRITIONAL PRODUCTS
MARKET SHARE OF CONTRACT RESEARCH
MARKET SHARE OF CONTRACT PACKAGING
Table 63 : CONTRACT PACKAGING MARKET SHARE, BY REGION, 2010
Figure 41 : CONTRACT PACKAGING MARKET SHARE, BY REGION, 2010

Chapter- 14: CONTRACT MANUFACTURING APPLICATIONS FOR NORTH AMERICAN MARKETS 16 $495
CARDIOVASCULAR DRUGS
REPRODUCTIVE DRUG MARKET
ONCOLOGY DRUG MARKET
ANALGESICS MARKET
ANTIVIRAL DRUG MARKET
ANTIBIOTICS MARKET
MARKETS FOR OTHER DRUGS

Chapter- 15: PATENT ANALYSIS 8 $248
PATENTS BY YEAR
PATENTS BY COMPANY
PATENTS BY COUNTRY
PATENTS BY EMPHASIS
Table 75 : PATENTS, BY EMPHASIS, 1/1/2009 TO 5/31/2011
Figure 54 : NUMBER OF U.S. PATENTS, BY EMPHASIS, 1/1/2009 TO 5/31/2011

Chapter- 16: CURRENT ENVIRONMENT 6 $186
SITUATION OF THE NORTH AMERICAN CONTRACTING MARKETS
SITUATION OF THE EUROPEAN CONTRACTING MARKET
SITUATION OF THE ROW CONTRACTING MARKET
OPPORTUNITIES AND CHALLENGES OF THE CURRENT CONTRACT MANUFACTURING INDUSTRY

Chapter- 17: COMPANY PROFILES 44 $1362
AAI PHARMA, INC.
ABBOTT LABORATORIES
AEROGEN LTD.
ALKERMES
ALTHEA TECHNOLOGIES
AMCOR
AMERISOURCE BERGEN CORPORATION
AMPAC FINE CHEMICALS
ALBANY MOLECULAR RESEARCH INC. (AMRI)
AP PHARMA INC.
APTUIT INC.
ARADIGM CORPORATION
BASF SE
BAXTER HEALTHCARE
BCM/BOOTS MANUFACTURING
BOEHRINGER INGELHEIM
BRISTOL-MYERS SQUIBB
CAMBREX CORPORATION
CANGENE CORPORATION
CATALENT PHARMA SOLUTIONS
CEDARBURG HAUSER PHARMACEUTICALS INC.
CENEXI
CHARLES RIVER LABORATORIES
CHEMBRIDGE CORP.
CLEARSTONE CENTRAL LABORATORIES
CONFAB LABORATORIES
COVANCE INC.
COVIDIEN
CONTRACT PHARMACEUTICALS LIMITED
CORDEN PHARMA SWITZERLAND LLC
DAVOS PHARMA
DECODE GENETICS
DISHMAN PHARMACEUTICALS AND CHEMICALS LTD.
DOW CHEMICAL
DPT LABORATORIES INC.
DR. REDDY’S LABORATORIES
DSM PHARMACEUTICAL PRODUCTS
FUJIFILM DIOSYNTH BIOTECHNOLOGY
ELAN DRUG TECHNOLOGIES
EVOTEC AG
FULCRUM PHARMA PLC
GIRINDUS AG
GLAXOSMITHKLINE
HOSPIRA
HAUPT PHARMA AG
HOVIONE S.A.
ICON PLC
INC RESEARCH, INC.
JUBILANT LIFESCIENCES
KENDLE INTERNATIONAL INC.
KP PHARMACEUTICAL TECHNOLOGIES INC.
K.V. PHARMACEUTICAL CO.
LIGAND PHARMACEUTICALS, INC.
LONZA GROUP
LYNE LABORATORIES
MERCK / MSD BIOMANUFACTURING NETWORK
MIKART INC
NEXTPHARMA TECHNOLOGIES
NORWICH PHARMACEUTICALS
NOVAVAX, INC.
OMNICARE CLINICAL RESEARCH
PAREXEL INTERNATIONAL CORPORATION
PATHEON INC.
PERRIGO COMPANY
PFIZER (KING PHARMACEUTICALS
PIRAMAL HEALTHCARE LIMITED
PPD
PRA INTERNATIONAL
QUINTILES
RANBAXY
REGIS TECHNOLOGIES, INC.
SKYEPHARMA
TALECRIS BIOTHERAPEUTICS INC.
VETTER PHARMA INTERNATIONAL GMBH
WOCKHARDT LIMITED
WUXI APP TEC
XCELLEREX LLC
ZACH SYSTEM S.P.A

Chapter- 18: APPENDIX I: ABBREVIATIONS 1 $31

List of Tables
Summary Table : GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE, THROUGH 2016
Table 1 : KEY DEVELOPMENTS IN THE HISTORY OF OUTSOURCING
Table 2 : KEY ADVANTAGES OF CONTRACT MANUFACTURING
Table 3 : KEY DISADVANTAGES OF CONTRACT MANUFACTURING
Table 4 : KEY FACTORS IN SELECTING A CONTRACT MANUFACTURER
Table 5 : SERVICES OF CONTRACT RESEARCH ORGANIZATIONS
Table 6 : KEY CHARACTERISITCS IN SELECTING A CONTRACT RESEARCH ORGANIZATION
Table 7 : TYPES OF RESEARCH PROVIDED BY CONTRACT RESEARCH ORGANIZATIONS
Table 8 : REASONS BEHIND NEEDING A CONTRACT PACKAGER
Table 9 : KEY CHARACTERISTICS IN SELECTING A CONTRACT PACKAGER
Table 10 : KEY STEPS IN HIRING A CONTRACT PACKAGER
Table 11 : STEPS OF PROJECT MANAGEMENT
Table 12 : PROCESSES OF PROJECT MANAGEMENT
Table 13 : KEY RESPONSIBILITIES OF PROJECT MANAGERS
Table 14 : TECHNOLOGY TRANSFER STEPS
Table 15 : REGULATED FACTORS OF CMO’S AND CRO’S
Table 16 : TITLE 21 CFR RULES ASSOCIATED WITH CONTRACT MANUFACTURING
Table 17 : WARNING LETTERS ISSUED TO CONTRACT MANUFACTURERS, 2010
Table 18 : WARNING LETTERS ISSUED TO CONTRACT MANUFACTURERS, 2009
Table 19 : REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND FACILITIES, JANUARY THROUGH MARCH, 2011
Table 20 : REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND FACILITIES, 2010
Table 21 : REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND FACILITIES, 2009
Table 22 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/API’S, IN NORTH AMERICA, 2010
Table 23 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, IN NORTH AMERICA, 2010
Table 24 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING NONSTERILE LIQUID DOSAGE FORMS, IN NORTH AMERICA, 2010
Table 25 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, IN NORTH AMERICA, 2010
Table 26 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, IN NORTH AMERICA, 2010
Table 27 : MARKET SHARE OF CONTRACT RESEARCH COMPANIES, IN NORTH AMERICA, 2010
Table 28 : MARKET SHARE OF CONTRACT PACKAGING COMPANIES, IN NORTH AMERICA 2010
Table 29 : BULK DRUG/API CONTRACT MANUFACTURING, FOR NORTH AMERICA, THROUGH 2016
Table 30 : SOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR NORTH AMERICA, THROUGH 2016
Table 31 : SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE, BY FORMULATION, FOR NORTH AMERICA, THROUGH 2016
Table 32 : SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES, BY FORMULATION, FOR NORTH AMERICA, 2010
Table 33 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING, FOR NORTH AMERICA, THROUGH 2016
Table 34 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING, FOR NORTH AMERICA, THROUGH 2016
Table 35 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING REVENUE, BY FORMULATION, FOR NORTH AMERICA, THROUGH 2016
Table 36 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, FOR NORTH AMERICA, 2010
Table 37 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE, BY FORMULATION, FOR NORTH AMERICA, THROUGH 2016
Table 38 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARE, BY FORMULATION, FOR NORTH AMERICA, 2010
Table 39 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR NORTH AMERICA, THROUGH 2016
Table 40 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE, BY FORMULATION, FOR NORTH AMERICA, THROUGH 2016
Table 41 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARE, BY FORMULATION, FOR NORTH AMERICA, 2010
Table 42 : CONTRACTING COMPANIES PROVIDING DRUG-DELIVERY SYSTEMS
Table 43 : ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY CONTRACT MANUFACTURING, FOR NORTH AMERICA, THROUGH 2016
Table 44 : ADVANCED DRUG DELIVERY SYSTEMS FOR NORTH AMERICA, BY CONTRACT MANUFACTURING REVENUE, BY FORMULATION, THROUGH 2016
Table 45 : ADVANCED DRUG DELIVERY SYSTEMS FOR NORTH AMERICA, BY CONTRACT MANUFACTURING MARKET SHARE, BY FORMULATION, 2010
Table 46 : OTC AND NUTRITIONAL PRODUCT REVENUE FOR NORTH AMERICA BY CONTRACT MANUFACTURING, THROUGH 2016 ($ BILLIONS)
Table 47 : OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING REVENUE BY FORMULATION FOR NORTH AMERICA, THROUGH 2016
Table 48 : OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING MARKET SHARE, BY FORMULATION, FOR NORTH AMERICA, 2010
Table 49 : CONTRACT RESEARCH REVENUE FOR NORTH AMERICA, THROUGH 2016
Table 50 : CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR NORTH AMERICA, THROUGH 2016
Table 51 : CONTRACT RESEARCH MARKET SHARE, BY DISCIPLINE, FOR NORTH AMERICA, 2010
Table 52 : CONTRACT PACKAGING REVENUE, FOR NORTH AMERICA, THROUGH 2016
Table 53 : CONTRACT PACKAGING REVENUE BY TYPE, FOR NORTH AMERICA, THROUGH 2016
Table 54 : CONTRACT PACKAGING MARKET SHARE, BY TYPE, FOR NORTH AMERICA, 2010
Table 55 : BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARE, BY REGION, 2010
Table 56 : SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARE, BY REGION, 2010
Table 57 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING MARKET SHARE, BY REGION, 2010
Table 58 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARE, BY REGION, 2010
Table 59 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES, BY REGION, 2010
Table 60 : DRUG DELIVERY CONTRACT MANUFACTURING MARKET SHARE, BY REGION, 2010
Table 61 : OTC AND NUTRITIONAL PRODUCTS CONTRACT MANUFACTURING MARKET SHARE, BY REGION, 2010
Table 62 : CONTRACT RESEARCH MARKET SHARE, BY REGION, 2010
Table 63 : CONTRACT PACKAGING MARKET SHARE, BY REGION, 2010
Table 64 : REVENUE FROM CONTRACT MANUFACTURERS OF CARDIOVASCULAR DRUGS, IN NORTH AMERICA, THROUGH 2016
Table 65 : REVENUE FROM CONTRACT MANUFACTURERS OF REPRODUCTIVE DRUGS, IN NORTH AMERICA, THROUGH 2016
Table 66 : REVENUE FROM CONTRACT MANUFACTURERS OF ONCOLOGY DRUGS, IN NORTH AMERICA, THROUGH 2016
Table 67 : REVENUE FROM CONTRACT MANUFACTURERS OF ANALGESICS, IN NORTH AMERICA, THROUGH 2016
Table 68 : REVENUE FROM CONTRACT MANUFACTURERS OF ANTIVIRALS, IN NORTH AMERICA, THROUGH 2016
Table 69 : REVENUE FROM CONTRACT MANUFACTURERS OF ANTIBIOTICS, IN NORTH AMERICA, THROUGH 2016
Table 70 : REVENUE FROM CONTRACT MANUFACTURERS OF OTHER DRUGS, IN NORTH AMERICA, THROUGH 2016
Table 71 : NUMBER OF SIGNIFICANT PATENTS, BY YEAR, 2009-2011
Table 72 : NUMBER OF U.S. PATENTS, BY COMPANY, 2009-2011
Table 73 : NUMBER OF U.S. PATENTS, BY COUNTRY, 1/1/2009 TO 5/31/2011
Table 74 : PATENT SHARES, BY COUNTRY, 1/1/2009 TO 5/31/2011
Table 75 : PATENTS, BY EMPHASIS, 1/1/2009 TO 5/31/2011

List of Figures
Summary Figure : GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE, 2009-2016
Figure 1 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/API’S, IN NORTH AMERICA, 2010
Figure 2 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, IN NORTH AMERICA, 2010
Figure 3 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING NONSTERILE LIQUID DOSAGE FORMS, IN NORTH AMERICA, 2010
Figure 4 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, IN NORTH AMERICA, 2010
Figure 5 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, IN NORTH AMERICA, 2010
Figure 6 : MARKET SHARE OF CONTRACT RESEARCH COMPANIES, IN NORTH AMERICA, 2010
Figure 7 : MARKET SHARE OF CONTRACT PACKAGING COMPANIES, IN NORTH AMERICA, 2010
Figure 8 : BULK DRUG/API CONTRACT MANUFACTURING, FOR NORTH AMERICA, 2009-2016
Figure 9 : SOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR NORTH AMERICA, 2009-2016
Figure 10 : SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE, BY FORMULATIONS, FOR NORTH AMERICA, 2009-2016
Figure 11 : SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES, BY FORMULATIONS, FOR NORTH AMERICA, 2010
Figure 12 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING, FOR NORTH AMERICA, 2009-2016
Figure 13 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING, FOR NORTH AMERICA, THROUGH 2016
Figure 14 : LIQUID DOSAGE FORM (NON STERILE) CONTRACT MANUFACTURING REVENUE, BY FORMULATION, FOR NORTH AMERICA, 2009-2016
Figure 15 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING MARKET SHARES, BY FORMULATION, FOR NORTH AMERICA, 2010
Figure 16 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE, BY FORMULATION, FOR NORTH AMERICA, 2009-2016
Figure 17 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARE, BY FORMULATION, FOR NORTH AMERICA, 2010
Figure 18 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR NORTH AMERICA, 2009-2016
Figure 19 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE, BY FORMULATION, FOR NORTH AMERICA, 2009-2016
Figure 20 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARE, BY FORMULATION, FOR NORTH AMERICA, 2010
Figure 21 : ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY CONTRACT MANUFACTURING, FOR NORTH AMERICA, THROUGH 2016
Figure 22 : ADVANCED DRUG DELIVERY SYSTEMS FOR NORTH AMERICA, BY CONTRACT MANUFACTURING REVENUE, BY FORMULATIONS, 2009-2016
Figure 23 : ADVANCED DRUG DELIVERY SYSTEMS FOR NORTH AMERICA, BY CONTRACT MANUFACTURING MARKET SHARE, BY FORMULATIONS, 2010
Figure 24 : OTC AND NUTRITIONAL PRODUCT REVENUE FOR NORTH AMERICA BY CONTRACT MANUFACTURING, 2009-2016
Figure 25 : OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING REVENUE, BY FORMULATION, FOR NORTH AMERICA, 2009-2016
Figure 26 : OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING MARKET SHARE, BY FORMULATIONS, FOR NORTH AMERICA, 2010
Figure 27 : CONTRACT RESEARCH REVENUE, FOR NORTH AMERICA, 2009-2016
Figure 28 : CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR NORTH AMERICA, 2009-2016
Figure 29 : CONTRACT RESEARCH MARKET SHARE, BY DISCIPLINE, FOR NORTH AMERICA, 2010
Figure 30 : CONTRACT PACKAGING REVENUE, FOR NORTH AMERICA, 2009-2016
Figure 31 : CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR NORTH AMERICA, 2009-2016
Figure 32 : CONTRACT PACKAGING MARKET SHARE, BY TYPE, FOR NORTH AMERICA, 2010
Figure 33 : BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARE, BY REGION, 2010
Figure 34 : SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARE, BY REGION, 2010
Figure 35 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING MARKET SHARE, BY REGION, 2010
Figure 36 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARE, BY REGION, 2010
Figure 37 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARE, BY REGION, 2010
Figure 38 : DRUG DELIVERY CONTRACT MANUFACTURING MARKET SHARE, BY REGION, 2010
Figure 39 : OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARE, BY REGION, 2010
Figure 40 : CONTRACT RESEARCH MARKET SHARE, BY REGION, 2010
Figure 41 : CONTRACT PACKAGING MARKET SHARE, BY REGION, 2010
Figure 42 : REVENUE FROM CONTRACT MANUFACTURERS OF CARDIOVASCULAR DRUGS, IN NORTH AMERICA, 2009-2016
Figure 43 : REVENUE FROM CONTRACT MANUFACTURERS OF REPRODUCTIVE DRUGS, IN NORTH AMERICA, 2009-2016
Figure 44 : REVENUE FROM CONTRACT MANUFACTURERS OF ONCOLOGY DRUGS, IN NORTH AMERICA, 2009-2016
Figure 45 : REVENUE FROM CONTRACT MANUFACTURERS OF ANALGESICS, IN NORTH AMERICA, 2009-2016
Figure 46 : REVENUE FROM CONTRACT MANUFACTURERS OF ANTIVIRALS, IN NORTH AMERICA, 2009-2016
Figure 47 : REVENUE FROM CONTRACT MANUFACTURERS OF ANTIBIOTICS, IN NORTH AMERICA, 2009-2016
Figure 48 : REVENUE FROM CONTRACT MANUFACTURERS OF OTHER DRUGS, IN NORTH AMERICA, 2009-2016
Figure 49 : NUMBER OF PATENTS, BY YEAR, 2009-MAY 31, 2011
Figure 50 : NUMBER OF PATENTS, BY YEAR, 2009-MAY 31, 2011
Figure 51 : NUMBER OF U.S. PATENTS, BY COMPANY, 2009-2011
Figure 52 : NUMBER OF U.S. PATENTS, BY COUNTRY, 1/1/2009 TO 5/31/2011
Figure 53 : PATENT SHARES, BY COUNTRY, 1/1/2009 TO 5/31/2011
Figure 54 : NUMBER OF U.S. PATENTS, BY EMPHASIS, 1/1/2009 TO 5/31/2011


Related Reports:  

 

Custom Research
If above report doesn't have the business information suitable for your business, we can provide custom research that would be lucrative for your business or enhance your profession. We leverage most comprehensive, affordable, high-quality custom research which will match exact topic & specifications of your choice. Please visit Custom Research page to make an enquiry.

 

Top Go to top of the page

product id: 208608, price: INR 327053, BCC Research

International Travel Grant for Members of
MANLIBNET (Management Libraries Network)
We accept
Phone: +91.22.27810772, 27810773
E-mail: info@bharatbook.com
Hours: Mon to Sat 8:00 AM to 8:00 PM IST
Call USA/Canada 1-866-279-8368
 
GPlus
About Trust Online